Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $6.41 million. The enterprise value is $3.09 million.
| Market Cap | 6.41M |
| Enterprise Value | 3.09M |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 6.41 million shares outstanding. The number of shares has increased by 145.84% in one year.
| Shares Outstanding | 6.41M |
| Shares Change (YoY) | +145.84% |
| Shares Change (QoQ) | +41.60% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 4.61% |
| Float | 6.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69
| Current Ratio | 5.69 |
| Quick Ratio | 4.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -320.96% and return on invested capital (ROIC) is -119.73%.
| Return on Equity (ROE) | -320.96% |
| Return on Assets (ROA) | -104.18% |
| Return on Capital (ROIC) | -119.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.72% in the last 52 weeks. The beta is 1.30, so ADIL's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -48.72% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 47.15 |
| Average Volume (20 Days) | 134,767 |
Short Selling Information
The latest short interest is 51,173, so 0.80% of the outstanding shares have been sold short.
| Short Interest | 51,173 |
| Short Previous Month | 77,821 |
| Short % of Shares Out | 0.80% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 0.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.27M |
| Pretax Income | -8.69M |
| Net Income | -12.24M |
| EBITDA | -7.27M |
| EBIT | -7.27M |
| Earnings Per Share (EPS) | -$4.60 |
Balance Sheet
| Cash & Cash Equivalents | 3.29M |
| Total Debt | n/a |
| Net Cash | 3.29M |
| Net Cash Per Share | $0.51 |
| Equity (Book Value) | 4.28M |
| Book Value Per Share | 1.00 |
| Working Capital | 3.15M |
Cash Flow
| Operating Cash Flow | -6.39M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.39M |
| FCF Per Share | -$1.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -145.84% |
| Shareholder Yield | -145.84% |
| Earnings Yield | -191.94% |
| FCF Yield | -100.17% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -49.14% |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |